Abstracts

Dual Roles of Plasmacytoid Dendritic Cells in HIV-1 Infection and Pathogenesis

Background: Plasmacytoid dendritic cells are potent type I interferon producing cells and crucial for controlling various viral infection. However, the contribution of pDC in HIV-1 infection and pathogenesis remains controversial. On one hand, pDC have been shown to inhibit HIV-1 replication through their IFN-I production. The numerical and functional decline of pDC in HIV-1 infected…

A Phase 2 Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Pulmonary TB Treatment

Background: Potent combination chemotherapy may allow reduction in duration of treatment required for drug-susceptible pulmonary TB. In the mouse model of TB treatment, intensive phase regimens containing rifapentine plus moxifloxacin have robust sterilizing activity. We assessed the antimicrobial activity, safety, and tolerability of a dual-substitution regimen containing rifapentine substituted for rifampin plus moxifloxacin substituted for…

Effect of Xpert MTB/RIF on Early Mortality in Adults with Suspected TB: A Pragmatic Randomized Trial

Background: South Africa has phased in Xpert MTB/RIF, replacing sputum smear microscopy in laboratories, as the first-line diagnostic test for tuberculosis (TB). In a pragmatic cluster randomized trial, we evaluated the effect of Xpert on early mortality in persons with suspected TB. Methodology: 20 laboratories in 4 provinces were randomized to intervention (immediate Xpert implementation)…

Xpert as the first line TB test in South Africa: yield initial loss to follow-up proportion treated

Background: South Africa has phased in Xpert MTB/RIF, replacing sputum smear microscopy in centralised laboratories, as the first-line test for tuberculosis (TB). In a pragmatic cluster-randomized trial, we evaluated the effect of Xpert implementation on yield, initial loss to follow-up and proportion treated. Methodology: 20 laboratories in 4 provinces were randomized to intervention (immediate Xpert…

14 Day EBA Study of PA-824 Bedaquiline *Pyrazinamide and Clofazimine in Smear Positive TB Patients

Background: Bedaquiline (B) and PA-824 (PA) have demonstrated potent bactericidal and sterilizing activity in combination with clofazimine (C) and pyrazinamide (Z) in murine models of TB. C is currently in use for multi-drug resistant TB, but its efficacy has not been established in controlled clinical trials. This study evaluated the 14 day early bactericidal activity…

CTX Prophylaxis Discontinuation Among ART-Treated Adults: A Randomized Non-Inferiority Trial

Background: Cotrimoxazole (CTX) prophylaxis is recommended by the WHO for all HIV-infected individuals in settings with high prevalence of HIV and infectious disease. These guidelines were developed prior to scale-up of antiretroviral therapy (ART). Following ART, the threshold for CTX discontinuation after ART initiation remains undefined in resource-limited settings. We conducted a randomized clinical trial…

Performance of the World Health Organization Algorithm*for Tuberculosis Screening in Kenya

Background: The World Health Organization (WHO) recommends tuberculosis (TB) intensified case finding (ICF) among people living with HIV (PLHIV) using an evidence-based clinical screening algorithm including current cough, fever, night sweats, and weight loss. However, limited data exist on the performance of this algorithm in routine program settings. We assessed the performance of the WHO…